SAPPT AWARDS $200,000 FOR COVID-19 VACCINE PROJECT
The San Antonio Partnership for Precision Therapeutics has awarded $200,000 for a collaborative study to develop a novel vaccine to combat COVID-19. Within days of the Stay Home/Work Safe directive issued by the City of San Antonio, the San Antonio Partnership for Precision Therapeutics (SAPPT) organized and issued a call for proposals to combat COVID-19. After a week, 17 proposals were received and one team was selected, a consortium of scientists from Southwest Research Institute (SwRI), Texas Biomedical Research Institute (Texas Biomed), The University of Texas at San Antonio (UTSA) and UT Health San Antonio. The Vaccine Development Center of San Antonio, which promotes collaboration in vaccine research, will contribute 25% of the $200,000 award to reflect the same shared mission of collaborative research across the 4-institute consortium.